Skip to main content
Yuyu Pharma, Inc. logo

Yuyu Pharma, Inc. — Investor Relations & Filings

Ticker · 000220 ISIN · KR7000220004 KO Manufacturing
Open in API
Filings indexed 304 across all filing types
Latest filing 2023-02-10 Earnings Release
Country KR South Korea
Listing KO 000220

About Yuyu Pharma, Inc.

https://www.yuyu.co.kr/

Yuyu Pharma, Inc., established in 1941, is a healthcare company focused on the development, manufacturing, and marketing of pharmaceutical products. The company is committed to creating innovative therapeutics to address healthcare challenges and improve quality of life. Its research and development efforts are concentrated on key therapeutic areas, with a notable emphasis on treatments for central nervous system disorders, including Alzheimer's disease. The company operates through several divisions, including Yuyu Healthcare, which provides pharmaceutical-standard Original Design Manufacturer (ODM) and Original Equipment Manufacturer (OEM) services.

Recent filings

Filing Released Lang Actions
매출액또는손익구조30%(대규모법인은15%)이상변경
Earnings Release Classification · 100% confidence The document is a regulatory filing from a Korean company (Yuyu Pharma) announcing a significant change in revenue or profit structure (30% or more). It provides preliminary financial results (sales, operating profit, net income) for the fiscal year compared to the previous year. This type of disclosure is a standard regulatory requirement in the Korean market (DART system) for reporting preliminary earnings before the final audit report is published. Since it is an initial announcement of financial results rather than a full annual report or a transcript, it falls under the Earnings Release category. FY 2022
2023-02-10 Korean
투자판단관련주요경영사항(특허권 취득)
Regulatory Filings Classification · 100% confidence The document is a regulatory filing from Yuyu Pharma regarding the acquisition of a patent for an eye disease treatment. It follows the standard format for 'Major Management Matters' (투자판단 관련 주요경영사항) in the Korean stock market, which is a specific type of regulatory disclosure. Since it does not fit into specific categories like M&A, dividends, or financial reports, it is classified as a general regulatory filing.
2023-02-07 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Financial Supervisory Service in South Korea. It details the acquisition of shares by an executive (Chun Jun-hee) of Yuyu Pharma. This type of filing is specifically categorized as a Director's Dealing (insider trade) report.
2023-01-26 Korean
임원ㆍ주요주주특정증권등소유상황보고서
Director's Dealing Classification · 100% confidence The document is a 'Report on Ownership of Specific Securities by Executives and Major Shareholders' (임원ㆍ주요주주 특정증권등 소유상황보고서) filed with the Korean Financial Supervisory Service. It details share acquisitions by an executive (Yoo Seung-pil) of Yuyu Pharma. This type of filing is specifically categorized as 'Director's Dealing' (DIRS) as it reports personal share transactions by company insiders.
2023-01-26 Korean
주식등의대량보유상황보고서(일반)
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Large Shareholding' (주식등의 대량보유상황보고서) filed with the Financial Services Commission and Korea Exchange. This type of filing is a regulatory requirement for entities or individuals who acquire a significant stake (typically 5% or more) in a publicly traded company, often referred to as a '5% rule' filing. In the provided taxonomy, this falls under 'Major Shareholding Notification' (MRQ).
2023-01-26 Korean
최대주주등소유주식변동신고서
Major Shareholding Notification Classification · 100% confidence The document is a 'Report of Change in Shareholding by Major Shareholders' (최대주주등소유주식변동신고서) for Yuyu Pharma. It details specific share transactions (purchases) made by major shareholders and executives, including dates, quantities, and updated ownership percentages. This falls under the category of 'Major Shareholding Notification' (MRQ), as it tracks changes in significant share ownership levels by insiders and major shareholders.
2023-01-26 Korean

Browse filings by year

9 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.